Basepoint Wealth’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.8K Hold
206
0.03% 210
2026
Q1
$54.9K Sell
206
-34
-14% -$9.21K 0.03% 204
2025
Q4
$60.4K Buy
+240
New +$63.7K 0.04% 190
2024
Q1
Sell
-1,101
Closed -$250K 118
2023
Q4
$250K Sell
1,101
-53
-5% -$11.1K 0.2% 88
2023
Q3
$232K Sell
1,154
-185
-14% -$39K 0.19% 91
2023
Q2
$278K Buy
1,339
+4
+0.3% +$776 0.23% 84
2023
Q1
$263K Sell
1,335
-59
-4% -$12.1K 0.22% 87
2022
Q4
$282K Buy
+1,394
New +$272K 0.25% 78

Other funds holding LH

Basepoint Wealth's LH Position: Q2 2026 in Review

Basepoint Wealth held its Labcorp (LH) position steady in Q2 2026 at 206 shares worth $57.8K. The position accounts for 0.03% of the portfolio, ranked #210.

Basepoint Wealth first reported a position in LH in Q4 2022 and has held it in 8 quarters since. The position peaked at $282K in Q4 2022. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Basepoint Wealth held 206 shares of Labcorp worth $57.8K as of Q2 2026.
  • Basepoint Wealth left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up 0.03% of Basepoint Wealth's portfolio in Q2 2026, its #210 holding.
  • Basepoint Wealth first reported a position in Labcorp in Q4 2022 and has held it in 8 quarters since.
  • Basepoint Wealth's Labcorp position peaked at $282K in Q4 2022.
  • 1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Basepoint Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.